Kardes Hakan 4
4 · Alignment Healthcare, Inc. · Filed Mar 19, 2025
Insider Transaction Report
Form 4
Kardes Hakan
Chief Experience Officer
Transactions
- Sale
Common Stock
2025-03-19$16.09/sh−4,229$68,036→ 688,585 total - Sale
Common Stock
2025-03-19$16.96/sh−2,373$40,243→ 686,212 total - Sale
Common Stock
2025-03-18$17.01/sh−25,000$425,193→ 692,814 total
Footnotes (5)
- [F1]Date of Rule 10b5-1 plan adoption: 03/14/2024
- [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.98 to $17.09. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
- [F4]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F5]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.